Recently developed gene set analysis methods evaluate differential expression patterns of gene groups instead of those of individual genes. This approach especially targets gene groups whose constituents show subtle but coordinated expression changes, which might not be detected by the usual individual gene analysis. The approach has been quite successful in deriving new information from expression data, and a number of methods and tools have been developed intensively in recent years. We review those methods and currently available tools, classify them according to the statistical methods employed, and discuss their pros and cons. We also discuss several interesting extensions to the methods.
INTRODUCTION
Since the advent of microarray technology, it has been of primary interest to identify differentially expressed genes (DEGs) and elucidate related biological processes. To this aim, a large number of statistical methods and tools have been developed in past decade. The most widely used approach, namely individual gene analysis (IGA), evaluates the significance of individual genes between two groups of samples compared. IGA typically yields a list of altered genes from a cutoff threshold. The list is then investigated with biologically defined gene sets derived from Gene Ontology or some pathway databases to assess the enrichment of specific biological themes in the list. Khatri and Draghici [1] and Rivals et al. [2] reviewed in detail the methods and tools for IGA.
The main problems of IGA originate from the use of the cutoff threshold value. First, the final result of IGA is significantly affected by the selected threshold, which is normally chosen arbitrarily [3] . Pan et al. [4] , while analyzing three microarray datasets, showed that different choices of the threshold value severely alter the biological conclusions (enrichment of specific function categories in the gene list). Second, many genes with moderate but meaningful expression changes are discarded by the strict cutoff value, which leads to a reduction in statistical power [3, 5] .
In recent years, gene set analysis (GSA) methods, free from the problems of the 'cutoff-based' methods, has received a great deal of attention ( Figure 1 ). GSA directly scores pre-defined gene sets for differential expression and especially aims to identify gene sets with 'subtle but coordinated' expression changes that cannot be detected by IGA methods. The key principle is that even weak expression changes in individual genes gathered to a large gene set can show a significant pattern. From a biological perspective, GSA methods are promising because functionally related genes often display a coordinated expression to accomplish their roles in the cell. By changing the focus from individual genes to a set of genes or pathways, the GSA approach enables the understanding of cellular processes as an intricate network of functionally related components [6] . Indeed, Mootha et al. [7] , whose work has inspired the development of various GSA methods, developed gene set enrichment analysis (GSEA) to identify a significantly altered gene set between microarray samples of diabetic and normal muscles for which no single gene was found to be differentially expressed by IGA. They found that genes involved in oxidative phosphorylation, whose expression was only modestly decreased in human diabetic muscle, were correlated with body aerobic capacity and associated with variations in human metabolism [7] . Ben-Shaul et al. [5] , while analyzing microarray data from the brains of MPTPinjected mice, showed that applying the GSA approach enabled the detection of many GO terms overlooked by IGA methods.
Another important problem with IGA is that all the statistical methods applied are based on the wrong assumption of independent gene (or genegroup) sampling, which increases false positive predictions. Some of the GSA methods also address this issue.
In this review, we compare and discuss the GSA methods and currently available tools that have been intensively developed in recent years to guide researchers to choose appropriate methods and tools for their own purposes. Additionally, several interesting extensions and applications of GSA are discussed. Researchers also may benefit from a recent review by Dopazo [6] .
GSA METHODS AND THEIR NULL HYPOTHESES
Even before the work of Mootha et al. [7] , a few works already applied the concept of cutoff-free group testing to analyze gene expression data. For example, Virtaneva et al. [8] prepared several functional categories (gene sets) using a SWISS-PROT database, calculated scores for the functional categories from expression data, and applied sample randomization to assess the significance of each category. Pavlidis et al. [9] developed a semisupervised method to score each pre-defined gene class, and investigated three metrics: the degree of co-expression, the significance of expression profiles in the context of experimental designs and the learnability of gene class.
Thereafter, various GSA methods have been developed (Table 1) based on different null hypotheses and statistical methods [3, [10] [11] [12] [13] . Tian et al. [10] classified two kinds of null hypotheses for testing the coordinated association of gene sets with a phenotype of interest. The first type hypothesizes the same level of association of a gene set with the given phenotype as the complement of the gene set (say, Q1). The second type only considers the genes within a gene set and hypothesizes that there is no gene in the gene set associated with the phenotype (say, Q2). The methods based on Q1 and Q2 were termed competitive and self-contained, respectively by Geoman and Buhlmann [11] . IGA is a twostep process which first selects some tens to hundreds of genes by an arbitrarily chosen cutoff and then, from the selected genes, infers the biological meaning of the gene expression data. In contrast, GSA is single-step process which in advance prepares gene sets from diverse sources as a testable hypothesis and then directly infers the biological meaning of gene expression data by applying either a sample or a gene randomization test.
According to this classification, Catmap [3] , PAGE [14] , T-profiler [15] , ErmineJ [16] and Q1 test of Tian et al. [10] are competitive methods, while the global test of Goeman et al. [17, 18] , SAFE [19] , Q2 test of Tian et al. [10] , PLAGE [20] , the multivariate approach of Kong et al. [21] and SAM-GS [22] are self-contained methods ( Table 1) . The competitive methods test the relative enrichment of DEGs in a gene set compared with the background set, and target gene sets with coordinated expression changes. However, this feature of relativism can cause the peculiar behavior of a 'zero-sum game' [23, 24] . For example, in an extreme case where all the genes are down-regulated under an experimental condition, some gene sets can be considered up-regulated by the background distribution. Moreover, most of the competitive methods suffer from the invalid assumption of independent gene sampling [11] . On the other hand, the self-contained methods use only the information contained in the given gene set. They provide very powerful predictions due to the strong hypothesis of Q2. However, in this case only a single DEG can make the whole gene set significant so that the gene sets may not be 'enriched' with DEGs. In this sense, self-contained methods target a larger class of DEG sets than those targeted by competitive methods.
INTERPRETING GSEA PROCEDURE
Unlike the methods described above, the widely known GSEA [7] tests another kind of hypothesis that 'none of the gene sets considered is associated with the phenotype' (say, Q3). The object Q3 validates is the entire dataset, and it tests whether the dataset contains any gene set that is associated with (1) For each observed score of a gene set, count the number of sample permutations for which a gene set with a better score than the observed is found. (2) For N sample permutations, count the numbers of gene sets that have a better score than a given threshold for the real dataset and permuted datasets, say k 0 and k 1 , . . . ,k N , respectively, and then, the number of cases for which
The first method assigns P-values to each gene set, while the second method assigns P-values only to the entire dataset. The original GSEA method focuses on the highest-scoring single gene set so that the above two methods coincide, and hence the P-value can be given to both the highest-scoring gene set and the entire dataset. In subsequent works, however, only the first method was used to derive multiple significant gene sets [25, 26] . An interesting analog of GSEA in a self-contained analysis of a gene set is suggested by Geoman and Buhlmann [11] . They applied the second type of P-value calculation to assess the significance of the gene set, and not of its constituents. In spite of the complicated interpretation of the P-value in the GSEA procedure, their method seems to provide a legitimate approach for identifying subtle but coordinated expression changes without violating the dependence of gene expression.
Many other highly sensitive methods are based on the invalid assumption of independent gene sampling for Q1 or on the strong Q2 hypothesis, and hence may not be directly compared with GSEA. Notwithstanding, improvements in the statistical power of GSEA have been achieved by combining various competitive score functions to the GSEA procedure. Originally, Mootha et al. [7] used an un-weighted Kolmogorov-Smirnov statistic, but they later improved it [25] by weighting each gene by the correlation with the phenotypes to prevent gene sets clustered in the middle of the ordered gene list from getting high scores [24] . Efron and Tibshirani [26] introduced five test statistics for a GSEA algorithmmean, mean.abs, maxmean, GSEA and GSEA.absto test five simulated conditions and concluded that the maxmean statistic is the only method with consistently low P-values in all situations.
There have been some criticisms of GSEA. Damian and Gorfine [24] illustrated two examples in which the GSEA procedure seemed to behave peculiarly: the enrichment score can be influenced by the size of a gene set and by the presence or absence of lower-ranking sets. Surely, those two peculiar behaviors stem from the competitive nature of the GSEA procedure. The first example simply shows the typical properties of statistical scores that usually depend on the number of samples. Virtaneva et al. [8] , Tian et al. [10] and Lee et al. [16] devised gene set scores that do not depend on the size of gene sets, and which one to use may depend on the preference of the user. However, it should be noted that subtle but coordinated expression changes are detectable only by taking into account the number of genes.
METHODS FOR P-VALUE CALCULATION
Many authors have discussed the differences between gene and sample randomization in inferring the statistical significance of gene set scores. Among them, Tian et al. [10] and Goeman and Buhlman [11] discussed the issue most comprehensively. Two different opinions exist on the gene versus sample randomization for calculating P-values. One group suggests that both gene and sample randomizations should be used because they test two different but complementary null hypotheses [10] . The other group insists that only sample randomization should be used to avoid inherent problems of the gene randomization method [11, 12, 22] .
According to Goeman and Buhlman [11] , gene randomization is problematic because the roles of samples and genes in classical statistical tests are reversed, which makes the interpretation of the P-value unclear. More importantly, the condition of independent gene sampling is not satisfied by the correlation structures among functionally related genes. In particular, the latter problem has well been recognized by many researchers [3, 8, 10, 12, 13, 16, 19-21, 25, 27] . Indeed, Breslin et al. [3] , Delongchamp et al. [27] , Kim et al. [13] and Geoman and Buhlmann [11] using real or carefully designed simulated datasets showed that a gene set with highly correlated genes tends to show a much smaller P-value than that without correlation, which increases false positive predictions. For this reason, the current consensus favors sample randomization over gene randomization as the more appropriate statistical test.
However, sample randomization is not without a problem. First, it requires a certain level of sample replicates to attain deep levels of significance, but this condition often is not met in many datasets such as time-series data or those designed to investigate the effects of diverse drugs in multiple conditions. For this reason, Subramanian et al. [25] included the gene randomization option in their GSEA program and suggested using gene randomization to generate hypothesis when the number of samples is small. The second problem is that sample randomization methods often identify too many gene sets as significant when there are many DEGs in the dataset [10, 11, 26] . From sample randomization, one or only a few DEGs in a gene set can easily reject the strong hypothesis Q2, and the original purpose of GSA, i.e. discovering significant patterns represented simply by a set may not be fulfilled. This is clearly observed in the following simulation study.
A SIMULATION STUDY: COMPARISON OF Q1, Q2 AND Q3
This study compares the distribution of P-values obtained from the three hypotheses Q1, Q2 and Q3 on simulated data. We generated expression profiles of 2000 genes with two sample groups, each having 20 samples. The expression values were sampled from a standard normal distribution in both groups. For 600 randomly selected genes (30%), we added a random value between 0.5 and 1 to the second group to generate DEGs. The genes were divided into 100 gene sets, each of which contained 20 genes. To compare the difference of the three hypotheses, we commonly used the average t-statistic in a gene set as the score function [10] . Since the DEGs were chosen uniformly at random, no gene sets were expected to be 'enriched' with DEGs. Indeed, the competitive method (Q1) recognized no DEG sets so the P-values were distributed uniformly ( Figure 2) . However, the self-contained method (Q2) detected most of the gene sets (83%) as differentially expressed with a P-value cutoff of 0.05. The mixed approach, GSEA exhibited an intermediate performance.
From this result, we confirmed the criterion for choosing a statistical method for GSA. If the purpose is to find gene sets relatively enriched with DEGs, a competitive method based on Q1 should be used. However, if the purpose is to find gene sets clearly separated between the two sample groups, a self-contained method based on Q2 should be selected. Our group prefers the mixed approach (Q3) to avoid the clear drawbacks of the other methods, but recommends using all the methods simultaneously, if possible, with biological analyses.
CURRENT TOOLS AND GENE SET DATABASES
Our group reviewed currently available GSA tools (Table 2) , which vary in statistical methods used (gene or sample randomization), the form of the provided tool (web server, standalone software, Excel add-ins, or command line scripts) and the applicable organisms. Because sample randomization generally takes much longer computation time than does gene randomization, most sample randomization-based methods are offered as standalone programs or command-line scripts, whereas Competitive (Q1) Self-contained (Q2) GSEA (Q3) Figure 2 : The P-value distributions of 100 gene sets for the three GSA approaches on simulated data.10 000 permutations were performed for gene or sample randomizations on the average t-score.
gene randomization-based methods are normally offered as web servers. In GSA, as important as the algorithms are the gene sets. They are prepared using diverse sources of biological knowledge such as the gene ontology information, cytogenetic bands, pathways such as KEGG, GenMAPP, and Biocarta, cis-acting regulatory motifs and co-regulated genes in a microarray study. The limitations and challenges of the information on current annotation databases for IGA are thoroughly reviewed by Khatri and Draghici [1] focusing on incomplete knowledge, time-delayed curation, imprecise or incorrect electronic annotations, inability to predict new functions and semantic misclassification of annotations. The problems are all shared by GSA except for finding more relevant categories among overlapping gene sets for which GSA is able to assign different scores. A second interesting extension is the absolute enrichment analysis that takes into account both up and down-regulated genes in calculating enrichment scores [19, 22, 26, 31] . For example, many enrichment scores are functions of the difference of means between two sample groups, and hence genes altered in the opposite directions in a gene set will cancel each other to make the score insignificant. By using absolute values on the difference of means, gene sets with bi-directional changes can be identified. This idea is helpful in identifying homeostatic systems that have bi-directional expression changes to maintain the constancy of the system [31] . The maxmean score suggested by Efron and Tibshirani [26] and some self-contained methods such as the multivariate method [21] and SAM-GS [22] also can be used to identify gene sets with bi-directional changes.
A third extension is the sample-level application of GSA. Recently, Bild et al. [32] and Potti et al. [33] developed genomic signatures to identify the activation status of oncogenic pathways and predict the sensitivity to individual chemotherapeutic drugs. Edelman et al. [28] developed a formal statistical method, named ASSESS (analysis of sample-set enrichment scores), to measure the enrichment of each gene set in an individual sample, and suggested extending their method into personalized identification and treatment. PLAGE [20] and domainenhanced analysis by Liu et al. [34] also are able to identify the enrichment of each gene set at the individual sample level because they first calculate gene set scores for each sample. Moreover, after an adequate normalization of expression data, many gene-sampling-based methods also can be used to identify the enrichment of each gene set in individual samples [10, 14, 16] .
Finally, another useful application of GSA is that the congruency between different datasets on the same biological question increases much more when compared at a gene set level than at an individual gene level. This point was briefly mentioned by Kim and Volsky [14] and Subramanian et al. [25] and was later systematically investigated by Cheadle et al. [35] and Manoli et al. [36] . Additionally, GSA methods are less sensitive to the pre-processing of microarray data than are IGA methods [14, 37] .
